A docetaxel based-combination may be an effective perioperative option for patients with gastric or gastro-esophageal cancer, according to the phase 2 results of a phase 2/3 study published in The Lancet Oncology.1
http://www.cancertherapyadvisor.com/gastrointestinal-gi-cancers-symposium/doxorubicin-based-perioperative-therapy-recommended-in-gastric-cancer/article/568180/
Doxorubicin-based Perioperative Therapy Recommended in Gastric Cancer